About I-Med Pharma
I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec. Specializing in dry eye diagnosis and management, I-MED Pharma provides Ocular Surface Disease (OSD) solutions to Canadian ophthalmologists, optometrists, and the global eye care community.
HOW WE BEGAN
I-MED Pharma dates-back to 1989, when Dr. Ilan Hofmann, PhD in biochemistry, and Maureen Blanchard opened a small office in Montreal under the name of Domilens Canada Inc., a subsidiary of the Lyon, France-based, Laboratoires Domilens. Dr. Hofmann and Ms. Blanchard grew Domilens Canada Inc. into a fully independent, wholly-owned Canadian company, which was renamed I-MED Pharma Inc. in 1994.
In 2017, Dr. Ilan Hofmann, transitioned from President and CEO of I-MED Pharma to Chairman and Chief Scientific Officer of the company. This allowed him to focus his attention on the research & development of new products, the backbone, and the future of the company. Daniel Hofmann, MBA, BSc in biochemistry, was appointed President and CEO and remains focused on the continued growth and expansion of the company, through both product development and global distribution partnerships.
As a research-based firm with the vision to be the most important dry eye and ocular surface disease company in the world, I-MED Pharma provides innovative OSD solutions to the global optometry and ophthalmology community. Through the years, I-MED Pharma has continuously invested heavily in R&D and has created unique and effective products for ophthalmic surgery and for the management of dry eye disease. A pioneer in the field of artificial tears and ocular hygiene cleansers, I-MED Pharma’s signature product lines include I-DROP® and I-LID ’N LASH®, which are now sold around the world.
I-MED Pharma offers a complete range of ocular surface disorder products, including diagnostic tools, artificial tears, ocular hygiene cleansers, IRPL® treatment solutions, punctum plugs, nutritional supplements, and therapeutic accessories.
With a drive to achieve our vision, I-MED Pharma continues to invest in researching the best, most effective solutions for dry eye disease. We have a strong manufacturing pipeline for all our current products, and we are actively developing additional products in the areas of lid hygiene, artificial tears, nutritional vitamins, and other innovative diagnostic devices and treatments.
Keeping the best interests of doctors and patients in mind, I-MED Pharma strives to constantly improve our products to maintain our leadership position in the dry eye market.
As a separate division of I-MED Pharma Inc., I-MED Animal Health is proud to offer global veterinarians and veterinary ophthalmologists superior, state-of-the-art diagnostic, surgical and OSD products manufactured with human quality standards and materials.